I agree that this site is using cookies. You can find further informations here.
X
Kubota, Ryuji
305  results:
Search for persons X
?
1

Clinical features, future cardiac events, and prognostic fa..:

Tatami, Yosuke ; Tanaka, Akihito ; Ohashi, Taiki...
Heart and Vessels.  39 (2024)  6 - p. 505-513 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Development of a SARS‐CoV‐2 viral dynamic model for patient..:

Yamaguchi, Daichi ; Shimizu, Ryosuke ; Kubota, Ryuji
CPT: Pharmacometrics & Systems Pharmacology.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy..:

Tanaka, Masakazu ; Takenouchi, Norihiro ; Arishima, Shiho...
International Journal of Molecular Sciences.  25 (2024)  13 - p. 6858 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Geographic characteristics of HTLV-1 molecular subgroups an..:

Nozuma, Satoshi ; Yoshimura, Akiko ; Pai, Shun-Chung...
PLOS Neglected Tropical Diseases.  18 (2024)  2 - p. e0011928 , 2024
Link: https://doi.org/10.1371/..
 
?
5

Effect of Renal Impairment on Pharmacokinetics and Safety o..:

Katsube, Takayuki ; Kezbor, Safwan ; Shimizu, Ryosuke.
Infectious Diseases and Therapy.  13 (2024)  3 - p. 597-607 , 2024
Link: https://doi.org/10.1007/..
 
?
6

Identification and tracking of HTLV-1–infected T cell clone..:

Nozuma, Satoshi ; Matsuura, Eiji ; Tanaka, Masakazu...
JCI Insight.  8 (2023)  7 - p. , 2023
Link: https://doi.org/10.1172/..
 
?
7

HTLV-1-associated myelopathy/tropical spastic paraplegia wi..:

Matsuura, Eiji ; Nozuma, Satoshi ; Shigehisa, Ayano...
BMC Musculoskeletal Disorders.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
8

Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTL..:

Matsuura, Eiji ; Nozuma, Satoshi ; Dozono, Mika...
Pathogens.  12 (2023)  4 - p. 592 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Population pharmacokinetics of duloxetine in Japanese pedia..:

Shibata, Risa Yokokawa ; Kubota, Ryuji ; Uenaka, Kazunori..
Drug Metabolism and Pharmacokinetics.  51 (2023)  - p. 100496 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Iliopsoas muscle weakness as a key diagnostic marker in HTL..:

Matsuura, Eiji ; Nozuma, Satoshi ; Dozono, Mika...
Journal of the Neurological Sciences.  455 (2023)  - p. 122746 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Evaluation of the Drug–Drug Interaction Potential of Ensitr..:

Shimizu, Ryosuke ; Sonoyama, Takuhiro ; Fukuhara, Takahiro...
Clinical Drug Investigation.  43 (2023)  5 - p. 335-346 , 2023
Link: https://doi.org/10.1007/..
 
?
12

530. Population Pharmacokinetic Analysis of Ensitrelvir, an..:

Ishibashi, Toru ; Nomura, Luna ; Shimizu, Ryosuke.
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
13

Performance evaluation of Espline HTLV-I/II, a newly develo..:

Kuramitsu, Madoka ; Momose, Haruka ; Uchida, Yuichiro...
Microbiology Spectrum.  11 (2023)  6 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
14

Evaluation of Drug‐Drug Interactions of Ensitrelvir, a SARS..:

Shimizu, Ryosuke ; Matsuzaki, Takanobu ; Oka, Ryoko...
The Journal of Clinical Pharmacology.  63 (2023)  8 - p. 918-927 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Pharmacokinetics, safety, and tolerability of single and mu..:

Sonoyama, Takuhiro ; Shimizu, Ryosuke ; Kubota, Ryuji...
Neuropsychopharmacology Reports.  43 (2023)  3 - p. 346-358 , 2023
Link: https://doi.org/10.1002/..
 
1-15